Psoriasis Drug Raptiva Withdrawn From Market After Links To Fatal Brain Infection
Genentech Inc. announced that it is withdrawing its psoriasis drug, Raptiva, after the U.S. Food & Drug Administration (FDA) linked the drug to a rare, but often fatal brain infection.

Raptiva Side Effects - Progressive Multifocal Leukoenephalopthy (PML)
The California-based firm Genentech is withdrawing its psoriasis drug Raptiva from the market because of reports of three confirmed, and one suspected, cases of progressive multifocal leukoenephalopthy (PML), a rare and usual ...

Raptiva Recall to be Completed by June 8th, 2009
The California-based biotech firm Genentech has announced the gradual withdrawal of its psorasis drug Raptiva from the market by June 8, 2009.

Psoriasis Drug Raptiva: What Is It & Why Was It Recalled?
Genentech Corporation is withdrawing its psoriasis drug Raptiva from the U.S. market after the U.S. Food & Drug Administration (FDA) warned that the drug has been linked to brain disease. So, what is Raptiva, why was it recal ...

Brain Infection PML & Raptiva's Recall: What Psoriasis Patients Should Know
Psoriasis patients taking Genentech's Raptiva are scrambling to find another drug to treat their skin disease now that the manufacturer has recalled the product as its been linked to Progressive Multifocal Leukoencephalopath ...